TY - JOUR T1 - SARS-CoV2 disrupts clinical research - the role of a rare disease-specific trial network JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.02114-2020 SP - 2002114 AU - van Koningsbruggen-Rietschel, Silke AU - Dunlevy, Fiona AU - Bulteel, Veerle AU - Downey, Damian AU - Dupont, Lieven Y1 - 2020/01/01 UR - //www.qdcxjkg.com/content/early/2020/07/23/13993003.02114-2020.abstract N2 - Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has disrupted clinical trials worldwide [1].这可能延迟批准新药并减少通过临床试验获取调查处理SARS-COV-2干扰临床试验时, 稀有疾病患者可能延迟获取新药调查显示欧洲囊性纤维化临床测试网络最适宜跟踪并处理这种中断问题ER-